专利委员会维持Seer纳米与微米颗粒蛋白富集专利有效性,驳回布鲁克子公司异议

美股速递
Mar 31

专利审判与上诉委员会近日作出裁决,驳回了布鲁克公司旗下子公司对Seer, Inc.一项关键专利提出的无效挑战。该专利涉及纳米及微米颗粒蛋白富集技术,是Seer蛋白质组学平台的核心知识产权之一。

委员会经全面审查后认定,涉诉专利的权利要求具备新颖性与非显而易见性,维持其全部法律效力。这一决定进一步巩固了Seer在蛋白质组学前沿技术领域的专利壁垒。

此次胜诉标志着Seer在保护其创新成果方面取得重要进展,为其商业化战略提供了强有力的法律保障。专利的确认将有助于公司持续推进基于纳米颗粒技术的蛋白质组学解决方案的开发与应用。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10